84 related articles for article (PubMed ID: 2235954)
1. [Natural antibodies, homoreactants and R-proteins in patients with tuberculosis after effective and insufficiently effective chemotherapy].
Vakhidova GA; Kul'berg AIa
Probl Tuberk; 1990; (7):55-7. PubMed ID: 2235954
[TBL] [Abstract][Full Text] [Related]
2. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea.
Azzurri A; Kanaujia GV; Sow OY; Bah B; Diallo A; Del Prete G; Gennaro ML
Int J Immunopathol Pharmacol; 2006; 19(1):199-208. PubMed ID: 16569358
[TBL] [Abstract][Full Text] [Related]
3. [Change in the content of serum immunoglobulins A, G, M in patients with pulmonary tuberculosis and alcoholism during antibacterial and anti-alcoholism therapy].
Maskeev KM; Kasenova SL
Probl Tuberk; 1991; (4):57-60. PubMed ID: 1852747
[TBL] [Abstract][Full Text] [Related]
4. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics in bacterial isolation and antigenemia in patients with infiltrative pulmonary tuberculosis].
Litvinov VI; Mikhaĭlova IV; Kapina MA; Baenskiĭ AV; Demíanenko NV
Probl Tuberk; 1994; (4):23-5. PubMed ID: 7984608
[TBL] [Abstract][Full Text] [Related]
6. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
Ivanova LA
Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of patients with destructive pulmonary tuberculosis with indomethacin and tuberculostatic preparations].
Litvin LM; Novosad MK
Vrach Delo; 1990 May; (5):76-8. PubMed ID: 2396403
[TBL] [Abstract][Full Text] [Related]
8. [Antibodies to mycobacterial antigens in patients with pulmonary tuberculosis].
Autenshlius AI; Shkunov AN; Tumanov IuV; Kuznetsova NB; Mikhaĭlova ES; Sedova IuV; Ogirenko AP
Probl Tuberk Bolezn Legk; 2004; (11):37-40. PubMed ID: 15751709
[TBL] [Abstract][Full Text] [Related]
9. [Systematic approach to detection of anti-idiotypic antibodies to antimycobacterial idiotype in man and animals].
Avdienko VG; Kondrashov SIu; Litvinov VI
Probl Tuberk; 1997; (6):61-2. PubMed ID: 9503940
[TBL] [Abstract][Full Text] [Related]
10. [Degradation products of cell receptors and natural antibodies in patients with various forms of pulmonary tuberculosis].
Vakhidova GA; Kul'berg AIa
Probl Tuberk; 1989; (8):50-3. PubMed ID: 2554277
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
Mishin VIu; Chukanov VI; Vasil'eva IA
Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of some immunological parameters in pulmonary tuberculosis].
Dubaniewicz A; Sztaba-Kania M; Hoppe A
Pol Merkur Lekarski; 2004 Feb; 16(92):123-7. PubMed ID: 15176294
[TBL] [Abstract][Full Text] [Related]
14. [Immunological bases of tuberculin therapy in combined treatment of patients with pulmonary tuberculosis].
Krylov VA; Gergert VIa; Korotkova ED; Pechaev MG; Kuz'mina NV; Baranova NI
Probl Tuberk; 1994; (5):21-3. PubMed ID: 7870717
[TBL] [Abstract][Full Text] [Related]
15. [State of immunity in patients with destructive infiltrative pulmonary tuberculosis after effective and ineffective therapy].
Pakhomov AM
Probl Tuberk; 1983 Sep; (9):23-6. PubMed ID: 6647440
[No Abstract] [Full Text] [Related]
16. [Very high frequency electromagnetic irradiation in multimodal treatment of patients with disseminated infiltrative pulmonary tuberculosis].
Iakovleva LP; Lineva ZE; Mozhokina GN
Probl Tuberk; 2001; (2):11-2. PubMed ID: 11490454
[TBL] [Abstract][Full Text] [Related]
17. [Antituberculosis antibodies in patients with tuberculosis during chemotherapy].
Stakhanov VA; Vasil'ev NA; Levi DT; Rukhamina ML
Probl Tuberk; 2001; (5):48-50. PubMed ID: 11588965
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of increased serum soluble interleukin-2 receptor levels in patients with pulmonary tuberculosis].
Chui JJ; Fan P; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):288-90, 318-9. PubMed ID: 7712570
[TBL] [Abstract][Full Text] [Related]
19. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods].
Smirnov GA; Valiev RSh
Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207
[TBL] [Abstract][Full Text] [Related]
20. [Complex treatment of destructive pulmonary tuberculosis].
Shul'ga IA; Znosenko VA; Sukhorukova IS; Davydova GN; Surovtseva EIa; Shlapakova MA; Pelipas IG
Probl Tuberk Bolezn Legk; 2003; (7):29-31. PubMed ID: 12939873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
